Rats given a lethal dose (LD99.9) of ammonium acetate (10.8 mmol/kg of body weight) were protected to the extent of 85 and 76% when previously injected with N-carbamoyl glutamate or L-arginine, respectively, at a level of 4 mmol/kg of body weight. At a dose of 1 mmol/kg of body weight, L-arginine protected 24%, while N-carbamoyl-L-glutamate protected 61 % of the animals. When a combination of N-carbamoyl-L-glutamate plus L-arginine (1 mmol each per kg of body weight) was injected, 100% of the rats were protected. The efficacy of N-carbamoyl-L-glutamate is related to its role as an activator of mitochondrial carbamoyl phosphate synthetase (EC 2.7.2.5) and its resistance to hydrolysis by tissue acylaminoacid acylase. N-Acetyl-IL-glutamate, the naturally occurring and most effective activator of mitochondrial carbamoyl phosphate synthetase, was relatively ineffective in protection against lethal dose of ammonium acetate, because of its ready hydrolysis by acylaminoacid acylase.
Ammonia is a relatively toxic metabolite in ureotelic terrestrial mammals. Ureotelism, in fact, serves to protect such animals from ammonia intoxication by the operation of a highly efficient metabolic pathway for conversion of ammonia to urea. The susceptibility to ammonia intoxication varies somewhat between mammalian species. Rats appear to be particularly sensitive.
An abbreviated representation of the pathway involved in urea biosynthesis in ureotelic animals is shown in Fig. 1 . It should be noted that the biosynthetic pathway is initiated in mitochondria by the activation of carbamoyl phosphate synthetase (EC 2.7.2.5) by N-acetyl-L-glutamate (reaction 2). The presence of an enzyme system that catalyzes the synthesis of N-acetyl-L-glutamate from acetylcoenzyme A plus glutamate, and which is specifically stimulated by arginine, has been recently described by Shigesada and Tatibana (1, 2) (reaction 1). The mitochondrial enzyme ornithine carbamoyltransferase (EC 2.1.3.3) catalyzes a reaction of carbamoyl phosphate with ornithine to form citrulline (reaction 3). These three enzymes, which are involved in the initial stages of u? ea biosynthesis, are restricted to liver mitochrondia. The enzymes that convert the ureido groups of citrulline to urea with the regeneration of ornithine, while most active in liver cytosol, are also present in other tissues (3, 4) . Thus, it is clear that urea biosynthesis in liver from ammonia and carbon dioxide is initiated in mitochondria, and that the mitochrondrial phase requires in addition to the enzymes carbamoyl phosphate synthetase and ornithine carbamoyltransferase an effective concentration of ATP, acetylglutamate [or an analogue (5, 6) ] to activate carbamoyl phosphate synthetase, and a sufficient concentration of ornithine to insure maximal utilization of carbamoyl phosphate to form citrulline.
The relative instability of carbamoyl phosphate (7, 8) necessitates its rapid conversion to citrulline. This rapid conversion is normally insured by an adequate level of ornithine and the relatively high level of ornithine carbamoyltransferase in liver mitochondria.
While N-acetyl-L-glutamate has been shown to be the naturally occurring activator of carbamoyl phosphate synthetase (9) , and to be the most effective of a series of compounds tested (4, 5) , other closely related analogues (e.g., N-carbamoyl-L-glutamate, 2-acetoxyglutarate) are also able to activate the enzyme, but with different Km values (6).
Greenstein and coworkers (10) (11) (12) (13) (14) demonstrated that certain amino acids, including essential amino acids, were highly toxic when injected intraperitoneally into rats. The toxicity was demonstrated to be due to ammonia intoxication resulting from rapid deamination of the amino acids. When arginine (or citrulline or ornithine) was added to an individual amino acid (17) . Evidence for the ready hydrolysis of N-acetyl-L-glutamate by hog-kidney acylase I is presented in Table 3 . It should be noted that Ncarbamoyl-L-glutamate is not hydrolyzed at all, even at an enzyme concentration 25 times that used with N-acetyl-Lglutamate. While other possible explanations for the greater efficacy of carbamoylglutamate might exist, such as rates of absorption from the peritoneal cavity, transport within the liver cell to the mitochondria, etc., it would seem that the ease of hydrolysis by tissue acylaminoacid acylases of acetylglutamate is the most important factor in explaining the lesser efficacy of acetylglutamate injected into the intact animal.
DISCUSSION
A rationale for the efficacy of the combination of carbamoylglutamate plus arginine in protecting against a toxic dose of ammonium acetate is provided in Fig. 1 . Because carbamoyl phosphate synthetase can function only if activated by its naturally occurring activator (N-acetyl-L-glutamate), or by an analogue (6, 18) , the initiation of ammonia conversion to urea is critically dependent on this step. The amount of Nacetyl-L-glutamate present in rat-liver mitochondria has recently been determined (2) . They found a concentration of 0.1-0.2 mM, which is of the same order as the Ka value found (18) for the purified carbamoyl phosphate synthetase (0.11 mM). The concentration of acetylglutamate about doubled on a high protein diet, in parallel with increased levels of carbamoyl phosphate synthetase and urea biosynthesis (2) . Apparently, the biosynthetic capacity of the acetylglutamate synthetase system is limited, and the level of acetylglutamate maintained in mitochondria is just barely sufficient to maintain an adequate level of activated carbamoyl phosphate synthetase. While arginine is capable of increasing the maximal velocity or acetylglutamate synthetase about 6-fold, and to stimulate the synthesis of acetylglutamate in mitochondria as much as 10-fold (1), it is not known whether the concentration of arginine needed for this stimulation exists in mitochondria. Shigesada and Tatibana (1) do point out, however, that the salutary effect of arginine in protecting against ammonia intoxication may possibly be functioning through this mechanism.
The striking effectiveness of N-carbamoyl-L-glutamate in protecting against ammonia intoxication can only be interpreted on the basis of its demonstrated capacity to activate carbamoyl phosphate synthetase (5, 6). As has been pointed out, Kim found that 75% of this compound was excreted unchanged in the urine 48 hr after injection, 65% of it appearing in the first 4 hr (15) . Thus, it is not likely that this compound is being converted to some other metabolite. When carbamoylglutamate was fed to rats at low levels (1.9 g/kg of ration), the rats had an increased capacity for citrulline synthesis by their liver mitochondria, as compared to rats fed a glutamatesupplemented diet (19) .
It is possible that the beneficial effect of the combination of carbamoylglutamate plus arginine is largely the result of their effect on carbamoyl phosphate synthetase activity, carbamoylglutamate by direct action and arginine by stimulation of the acetylglutamate synthetase system. However, early experiments of Greenstein (10) (11) (12) (13) (14) showed that.the salutary effect of arginine could be duplicated by ornithine and citrulline, a finding that can only mean that arginine, in addition to its possible role as a stimulator of acetylglutamate synthetase, must be serving as a source of intramitochondrial ornithine. Because of the relatively high level of activity of ornithine carbamoyltransferase as compared to carbamoyl phosphate synthetase in mitochondia (20) , the concentration of ornithine normally present in mitochondria may be too low to insure saturation. Elevation of the intramitochondrial concentration of ornithine as a result of arginine feeding could thus be expected to provide more favorable conditions for rapid conversion of low levels of carbamoyl phosphate. While the mechanism of liver ornithine carbamoyltransferase is ordered, with carbamoyl phosphate binding first and ornithine second (8) , the rate of the reaction will of course not be optimal if the ornithine level is not high enough to insure saturation.
Chiosa et al. (21) reported that N-acetylglutamate, Nacetylaspartate, N-carbamoylglutamate, and N-carbamoylaspartate all provided "significant protection" at levels of 5-6 mmol/kg in mice given an LD70-o dose of NH4Cl. The data as reported, however, showed inconsistencies between groups. The effect of the combination of N-carbamoylglutamate plus arginine was not reported.
Hyperammonemia is associated clinically with serious disturbances in cerebral function (22, 23) . In adults, the condition is most frequently the result of hepatic failure; the term hepatic encephalopathy has been used to describe this condition . (23) . While therapy in these cases has been directed toward lowering the sources of ammonia (low protein intake, reduction of intestinal sources of ammonia by use of antibiotics and other agents, etc) (24, 25) , direct therapy has involved the use of arginine or a combination of arginine and glutamic acid (22, 26, 27) . The rationale for the use of arginine stems from the studies of Greenstein and coworkers discussed earlier, and that for glutamic acid is based on its potential as a substrate for glutamine synthesis in extrahepatic tissues (28, 29) [as well as to adults (30, 31) ] is also frequently associated with hyperammonemia. The potential benefit of parental feeding of amino acids to malnourished infants and adults thus must be balanced against the potential hazard of hyperammonemia.
In conditions of hyperammonemia of infants associated with genetic disorders involving enzymes of the ornithineurea cycle, the capacity for urea biosynthesis appears to be impaired in most instances because of a failure of the ornithine urea cycle to operate efficiently in the face of higher than minimal levels of ammonia (32) . Thus, therapy is directed to lowering ammonia intake by means of a low-protein diet and by lowering of intestinal sources of ammonia. The possibility of enhancing the efficiency of the urea biosynthetic pathway by increasing the level of activated carbamoyl phosphate synthetase (via carbamoyl glutamate) plus an increase in ornithine (via arginine) has not been reported.
An area of possible value for an agent that can protect against ammonia intoxication is that of urea feeding of ruminants. While the purpose of dietary feeding of urea supplements is to provide a cheap nitrogen precursor of protein by exploitation of the capacity of rumen microorganisms to convert urea to ammonia, and in turn to utilize the ammonia for protein synthesis, a complication is occasionally experienced in the way of seriqus hyperammonemia of the host animal (33) . While the use of arginine plus carbamoyl glutamate would not be expected to influence the rumen conversion of urea nitrogen to protein nitrogen, it could serve to protect the host animal against ammonia intoxication by increasing the rate of conversion of absorbed ammonia to urea. Supported in part by grants to P. P. C. from the Wisconsin Alumni Research Foundation and from the National Cancer In-
